Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
12/17/1997 | EP0719277B1 Androstenones |
12/17/1997 | EP0698025B1 Ampa antagonists and a method of treatment therewith |
12/17/1997 | EP0651743B1 Indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors |
12/17/1997 | EP0515550B1 Heparin neutralization with platelet factor 4 |
12/17/1997 | EP0202276B2 Composition for the treatment of psoriasis |
12/17/1997 | CN1168138A Aryl and heteroaryl purine compounds |
12/17/1997 | CN1167763A Acids and esters of diosmetin and pharmaceutical compositions containing them |
12/17/1997 | CN1167762A Tetrahydroisoquinoline derivatives and their use |
12/17/1997 | CN1167759A Substd. 2-naphthoyl guanidines, their preparing method, use and drug contg. them |
12/17/1997 | CN1167617A Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
12/16/1997 | US5698706 Heterocyclic amides and methods of use |
12/16/1997 | US5698691 Condensed cyclic compounds and their use |
12/16/1997 | US5698690 Hydroxamic acid derivatives with tricyclic substitution |
12/16/1997 | US5698595 Use of sulfonic acids as anti-ageing agents in a cosmetic or dermatological composition |
12/16/1997 | US5698578 Protein kinase C inhibitors |
12/16/1997 | US5698577 Compositions of bicyclic β-lactams and uses thereof |
12/16/1997 | US5698573 Imidazolone and oxazolone derivatives as dopamine antagonists |
12/16/1997 | US5698571 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine |
12/16/1997 | US5698567 Heterocyclic spiro compounds |
12/16/1997 | US5698553 Nervous system disorders |
12/16/1997 | US5698551 Treatment of diabetic neuropathy, migraines, neurogenic inflammation, rheumatic arthritis and insulin resistance |
12/16/1997 | US5698542 Compound comprising tetracycline type antibiotic linked to steroid type hormone |
12/16/1997 | US5698535 SIN-1A cyclodextrin inclusion complexes |
12/16/1997 | US5698523 Acylated enol derivatives as prodrugs of elastase inhibitors |
12/16/1997 | US5698520 Peptide related to human programmed cell death and DNA encoding the same |
12/16/1997 | US5698519 Polypeptide specifically inhibiting cathepsin L |
12/16/1997 | US5698403 Methods of detecting platelet-activating factor acetylhydrolase using antibodies |
12/16/1997 | US5697902 Treating patient with antibody or antibody fragment conjugated to cytotoxic agent |
12/16/1997 | CA2122002C Alteration of rate and character of hair growth |
12/16/1997 | CA2086432C 3-(1-substitutedpyrazoyl)-2-oxindole derivatives |
12/16/1997 | CA1339584C 2-substituted ergolines, their production and use |
12/11/1997 | WO1997046687A1 Vectors comprising sar elements |
12/11/1997 | WO1997046685A1 Polynucleotides encoding secreted proteins from human dendritic cells |
12/11/1997 | WO1997046683A2 Polynucleotides encoding secreted proteins |
12/11/1997 | WO1997046682A2 Polynucleotides from human adult pbmc encoding secreted proteins |
12/11/1997 | WO1997046672A2 Antisense nucleic acids and hammerhead ribozymes |
12/11/1997 | WO1997046671A1 Enhanced efficacy of liposomal antisense delivery |
12/11/1997 | WO1997046570A1 Oligoribonucleotides and ribonucleases for cleaving rna |
12/11/1997 | WO1997046565A1 SELECTED DERIVATIVES OF K-252a |
12/11/1997 | WO1997046561A1 Improved methods for the synthesis of chemical compounds having pde-iv inhibitory activity |
12/11/1997 | WO1997046556A1 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
12/11/1997 | WO1997046554A1 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
12/11/1997 | WO1997046551A1 Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors |
12/11/1997 | WO1997046526A1 Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production |
12/11/1997 | WO1997046524A1 Novel pyrrole derivatives |
12/11/1997 | WO1997046522A1 Novel vitamin d analogues |
12/11/1997 | WO1997046521A1 Nitrate esters and their use for neurological conditions |
12/11/1997 | WO1997046511A1 Coumpounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
12/11/1997 | WO1997046257A1 A method for enhancing long-term memory in a subject and uses thereof |
12/11/1997 | WO1997046234A1 Pharmaceutical compositions containing mesembrine and related compounds |
12/11/1997 | WO1997046233A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a) |
12/11/1997 | WO1997046226A2 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS |
12/11/1997 | WO1997046208A2 Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
12/11/1997 | WO1997046118A1 Dietetic foods containing conjugated linoleic acids |
12/11/1997 | WO1997040017A3 Modulators of molecules with phosphotyrosine recognition units |
12/11/1997 | CA2257299A1 Use of inhibitors of the cellular na+/h+ exchanger (nhe) for production of a medicament for the normalization of serum lipids |
12/11/1997 | CA2257206A1 Oxadiazole benzenesulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity |
12/11/1997 | CA2257074A1 A method for enhancing long-term memory in a subject and uses thereof |
12/11/1997 | CA2256653A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a) |
12/11/1997 | CA2256522A1 Polynucleotides encoding secreted proteins |
12/11/1997 | CA2256520A1 Polynucleotides encoding secreted proteins from human dendritic cells |
12/11/1997 | CA2256484A1 Vectors comprising sar elements |
12/11/1997 | CA2256456A1 Enhanced efficacy of liposomal antisense delivery |
12/11/1997 | CA2254716A1 Dietetic foods containing conjugated linoleic acids |
12/10/1997 | EP0811686A2 Human platelet-derived growth factor receptors |
12/10/1997 | EP0811685A2 Human platelet-derived growth factor receptors |
12/10/1997 | EP0811622A1 3-(Piperi-4-yl) 1,2-benzisoxazole and 3-(piperazin-4-yl) 1,2-benzisoxazole derivatives, processes for their preparation and pharmaceutical compositions containing them |
12/10/1997 | EP0811621A2 Carbamoyl substituted oxazoles as thromboxane receptor antagonists |
12/10/1997 | EP0811374A1 Combination dosage form comprising cetirizine and pseudoephedrine |
12/10/1997 | EP0811160A1 Nf-kappa b activation regulatory protein, i-kappa b-beta |
12/10/1997 | EP0811159A1 A process for identifiying pharmaceutically active agents using an epitope-tagged library |
12/10/1997 | EP0811059A1 Human chemokine beta-11 and human chemokine alpha-1 |
12/10/1997 | EP0811057A1 Viral preparations, vectors, immunogens, and vaccines |
12/10/1997 | EP0811011A1 Carbohydrate conjugated bio-active compounds |
12/10/1997 | EP0811001A1 Benzothiazine dioxides as endothelin antagonists |
12/10/1997 | EP0810991A1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists |
12/10/1997 | EP0810875A1 Multifunctional enzyme |
12/10/1997 | EP0810866A1 Use of acid-sensitive organo- transition metal compounds in cancer treatment |
12/10/1997 | EP0810864A1 2,6-diaryl pyridazinones with immunosuppressant activity |
12/10/1997 | EP0810863A1 Method of treating adenosine depletion |
12/10/1997 | EP0810829A1 Amino acid compositions and use thereof in clinical nutrition |
12/10/1997 | EP0641302B1 Alcohols as potassium channel openers and in treatment of urinary incontinence |
12/10/1997 | EP0355088B1 Sulphated polysaccharides having anti-metastatic activity |
12/10/1997 | CN1167487A Oxazolyl-and thiazolylimidazo- and thienodiazepines and their use as medicaments |
12/10/1997 | CN1167437A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
12/10/1997 | CN1166964A Massage oil for skin |
12/10/1997 | CN1036652C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present |
12/09/1997 | US5696267 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
12/09/1997 | US5696167 4-mercaptobenzoylguanidine derivatives |
12/09/1997 | US5696162 Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compound having retinoid like biological activity |
12/09/1997 | US5696151 Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants |
12/09/1997 | US5696146 3-((2,2-disubstituted-1,3-benzodioxolan-5-yl)methylcarbonyl) indole derivatives; useful for treating acne vulgaris, alpecia, seborrhoea, female hirsutism, benign prostatic hypertrophy and male pattern baldness |
12/09/1997 | US5696145 Vasopressin and oxytocin receptor |
12/09/1997 | US5696138 Urea derivatives and their use |
12/09/1997 | US5696137 Azaheterocyclymethyl-chromans |
12/09/1997 | US5696136 Method of treating psychosis using azaheterocyclylmethyl |
12/09/1997 | US5696135 Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
12/09/1997 | US5696129 5-HT4 antagonists |
12/09/1997 | US5696122 Indole and indoline derivatives as 5HT1D receptor antagonists |
12/09/1997 | US5696109 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |